Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rural Medicine A Tough Road To Travel – PharmAsia Summit

This article was originally published in PharmAsia News

Executive Summary

Many drug companies make it policy to try and reach all possible patients, but struggle to understand complex distribution systems in countries like China to reach low-income and rural patients.

You may also be interested in...



Merck, Simcere Form JV To Expand Access To Lifestyle Drugs Across China

SHANGHAI - Merck & Co. affiliate MSD signed an agreement to form a joint venture July 21 with Simcere Pharmaceutical Group that will see both companies expand access to critical lifestyle drugs across China

Sandoz, Taiwan’s TLC Ink Commercialization Deal For AmBisome Generic In U.S., EU

Sandoz will commercialize TLC’s liposomal amphotericin B product, a generic of Gilead’s AmBisome, in the U.S. and EU.

Taiwan Liposome Seeks To Teach Old Drugs New Tricks In China And Markets Far From Home

Taiwan Liposome Co. Ltd. has the funds and team to reach outside of its base in Taiwan to turn old drugs into new products and is looking for opportunities at Asia-specific product applications.

Topics

Related Companies

UsernamePublicRestriction

Register

SC079495

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel